Work

DNA repair deficiency biomarkers and identification of ER-positive breast cancer patients who may benefit from veliparib/carboplatin: Results from the I-SPY 2 trial.

Year: 2015

Type: article

Source: Journal of Clinical Oncology

Authors: Laura van’t Veer, Laura Esserman, Ashish Sanil, Annuska M. Glas, Tessa Severson, Sabine C. Linn, Lamorna Brown Swigart, Gillian L. Hirst, I-SPY Investigators, Olufunmilayo I. Olopade, Hope S. Rugo, Don Berry, Denise M. Wolf, Christina Yau

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601931106

FWCI:

Cites:

Cited by: 1

Related to: 20